X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Aventis Pharma Fact Sheet, Aventis Pharma Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aventis Pharma Fact Sheet   (HOCM)

Here is the latest financial fact sheet of Aventis Pharma. For more details, see the Aventis Pharma quarterly results and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANOFI INDIA Price History

Price Rs 4,709.0
Mkt Cap Rs m 108,448
Vol '000 0.2
P/E X 32.8
P/CF X 25.3
EPS (TTM) Rs 143.6
% ch % 0.1
No. of shares m 23.03
% ch week % 0.2
% ch 1-mth % 2.3
% ch 12-mth % 13.6
52 week H/L Rs 4,945.0/3,901.0
(As on Jan 16, 2018 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANOFI INDIA Financials

No. of Mths
Year Ending
12
Dec-12
12
Dec-13
12
Dec-14
12
Dec-15
12
Dec-16
5-Yr Chart
Click to enlarge
SANOFI INDIA EQUITY SHARE DATA
High Rs2,3992,8623,8004,5214,560 
Low Rs2,1962,4502,5003,4454,400 
Sales per share (Unadj.) Rs683.0785.4858.7952.31,028.5 
Earnings per share (Unadj.) Rs76.7115.1114.5139.6129.0 
Diluted earnings per shareRs76.7115.1114.5139.6129.0 
Cash flow per share (Unadj.) Rs115.7155.2156.4188.7186.0 
Dividends per share (Unadj.) Rs33.0045.0045.0065.0068.00 
Adj. dividends per shareRs33.0045.0045.0065.0068.00 
Dividend yield (eoy) %1.41.71.41.61.5 
Book value per share (Unadj.) Rs522.8584.8645.2706.5753.6 
Adj. book value per shareRs522.8584.8645.2706.5753.6 
Shares outstanding (eoy) m23.0323.0323.0323.0323.03 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.43.43.74.24.4 
Avg P/E ratio x30.023.127.528.534.7 
P/CF ratio (eoy) x19.917.120.121.124.1 
Price / Book Value ratio x4.44.54.95.65.9 
Dividend payout %43.039.139.346.652.7 
Avg Mkt Cap Rs m52,91161,16872,54591,724103,174 
No. of employees `0003.23.33.43.73.6 
Total wages/salary Rs m2,1382,4212,8823,3333,592 
Avg. sales/employee Rs Th4,971.75,496.45,735.25,987.06,537.7 
Avg. wages/employee Rs Th675.7735.7836.0909.9991.4 
Avg. net profit/employee Rs Th558.3805.8764.5877.7819.8 
SANOFI INDIA INCOME DATA
Net Sales Rs m15,73018,08919,77521,93023,686 
Other income Rs m412579643514708 
Total revenues Rs m16,14218,66720,41822,44424,394 
Gross profit Rs m3,1183,9793,3894,5915,281 
Depreciation Rs m8999239661,1301,313 
Interest Rs m1445415 
Profit before tax Rs m2,6173,6313,0613,9704,661 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m02546668390 
Tax Rs m8511,2331,0901,5941,691 
Profit after tax Rs m1,7672,6522,6363,2152,970 
Gross profit margin %19.822.017.120.922.3 
Effective tax rate %32.534.035.640.136.3 
Net profit margin %11.214.713.314.712.5 
SANOFI INDIA BALANCE SHEET DATA
Current assets Rs m8,2879,47112,62812,43715,673 
Current liabilities Rs m3,8664,6896,5586,1706,678 
Net working cap to sales %28.126.430.728.638.0 
Current ratio x2.12.01.92.02.3 
Inventory Days Days6369888076 
Debtors Days Days2324212422 
Net fixed assets Rs m7,4288,3488,5828,7718,098 
Share capital Rs m230230230230230 
"Free" reserves Rs m11,66513,09914,55916,00417,088 
Net worth Rs m12,04113,46714,85816,27217,356 
Long term debt Rs m00000 
Total assets Rs m16,31318,78322,27624,04625,400 
Interest coverage x187.9865.5638.6993.5311.7 
Debt to equity ratio x00000 
Sales to assets ratio x1.01.00.90.90.9 
Return on assets %10.914.111.913.411.8 
Return on equity %14.719.717.719.817.1 
Return on capital %21.928.925.129.626.9 
Exports to sales %15.623.024.224.224.5 
Imports to sales %27.530.236.926.128.0 
Exports (fob) Rs m2,4474,1524,7885,3125,801 
Imports (cif) Rs m4,3265,4557,2985,7206,627 
Fx inflow Rs m3,2034,8655,4956,6807,145 
Fx outflow Rs m4,8656,0948,0456,5876,846 
Net fx Rs m-1,662-1,229-2,55093299 
SANOFI INDIA CASH FLOW
From Operations Rs m 2,898 2,726 2,650 2,132 3,226 
From Investments Rs m -54 -3,354 613 359 -1,555 
From Financial Activity Rs m -897 -1,050 -1,217 -1,470 -1,818 
Net Cashflow Rs m 1,946 -1,678 2,046 1,021 -147 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 60.4%
Indian inst/Mut Fund 14.4%
FIIs 14.6%
ADR/GDR 0.0%
Free float 10.5%
Shareholders 15,184
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Aventis House, 54/A, Mathuradas Vasanji Road, Andheri (E), Mumbai-93
E-MAIL k.subramani@sanofi.com WEB www.sanofiindialtd.com
TELEPHONE (022) 2827 8000 FAX (022) 2837 0939
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR S. R. Batliboi & Co.
CHM: Vijay Mallya COMP SEC: K. Subramani YEAR OF INC: 1956 BSE CODE: 500674 FV (Rs): 10 DIV YIELD (%): 1.4

More Pharmaceuticals Company Fact Sheets:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare SANOFI INDIA With:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - WOCKHARDT LTD. COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS